Sadness is one of the small number of human emotions that have been recognized in all societies and time periods. Some of the earliest known epics, such as The Iliad and Gilgamesh, feature protagonists’ intense sadness after the loss of close comrades. Likewise, anthropological work across a great range of societies clearly describes emotions of sadness that develop in response to frustration in love, humiliation by rivals or the inability to achieve valued cultural goals.
Even primates display physiological and behavioral signs after losses that are unmistakably similar to sadness among humans. There is little doubt that evolution designed people to have a propensity to become sad after such situations.
Depressive mental disorders have also been known for as long as written records have been kept. Writing in the 5th century BC, Hippocrates provided the first known definition of melancholia (what we now call “depression”) as a distinct disorder: “If fear or sadness last for a long time it is melancholia.”
The symptoms that Hippocrates associated with melancholic disorder — “aversion to food, despondency, sleeplessness, irritability, restlessness” — are remarkably similar to those contained in modern definitions of depressive disorder.
Like Hippocrates, physicians throughout history have recognized that the symptoms of normal sadness and depressive disorder were similar.
Depressive disorders differed from normal reactions because they either arose in the absence of situations that would normally produce sadness or were of disproportionate magnitude or duration relative to whatever cause provoked them.
Such conditions indicated that something was wrong with the individual, not with his environment. Traditional psychiatry thus adopted a contextual approach to diagnosing a depressive disorder. Whether a condition was diagnosed as disordered depended not just on the symptoms, which might be similar in normal sadness, and not just on the condition’s severity, for normal sadness can be severe and disordered sadness moderate, but on the degree to which the symptoms were an understandable response to circumstances.
The distinction between contextually appropriate sadness and depressive disorders remained largely unchanged for two and a half millennia. But the psychiatric profession abandoned this distinction in 1980 when it published the third edition of its official diagnostic manual, the DSM-III.
The definition of Major Depressive Disorder (MDD) became purely symptom-based. All conditions that display five or more of nine symptoms — including low mood, lack of pleasure, sleep and appetite difficulties, inability to concentrate, and fatigue — over a two-week period are now considered depressive disorders.
The sole exception is “uncomplicated” grief-related depression. Symptoms otherwise meeting the DSM criteria are not considered disorders if they arise after the death of an intimate, do not last more than two months, and do not include certain particularly severe symptoms. Yet comparable symptoms that arise after, say, dissolution of a romantic relationship, loss of a job or diagnosis of a life-threatening illness are not excluded from diagnosis of disorders.
The DSM-III’s confusion of normal intense sadness and depressive mental disorder, which persists to the present, emerged inadvertently from psychiatry’s response to challenges to the profession during the 1970s. A powerful group of research psychiatrists was dissatisfied with the definitions of depression and other common mental disorders in the earlier, psychoanalytically influenced diagnostic manuals.
These earlier definitions separated feelings of sadness proportionate to contextual loss from those excessive to their contexts, and defined only the latter as disordered. But they also assumed that unconscious, unresolved psychological conflicts caused depression.
In order to abolish this unwarranted psychoanalytic assumption, the researchers abandoned the attempt to distinguish natural from disordered conditions by context or etiology and assumed that all conditions that met the symptom-based criteria were disordered.
The new definition of depression has resulted in extensive medicalization of sadness. Parents whose child is seriously ill, spouses who discover their partner’s extramarital affairs or workers unexpectedly fired from valued jobs are defined as suffering mental disorders if they develop enough symptoms to meet the DSM criteria. This is the case even if the symptoms disappear as soon as the child recovers, the spouses reconcile or a new job is found.
The medicalization of sadness has proven to be of tremendous benefit to the mental health and medical professions. Millions of people now seek professional help for conditions that fall under the medicalized, overly inclusive definition of depression. Indeed, depression is now the most commonly diagnosed condition in outpatient psychiatric treatment.
The medicalization of depression has proven to be even more profitable for pharmaceutical companies, whose sales of anti-depressant medications have soared. While it is impossible to know what proportion of these people are experiencing normal sadness that would go away with the passage of time or a change in social context, it is almost certainly very high.
It would not be hard for psychiatry to develop a more adequate definition of depressive disorder that de-medicalizes natural emotions of sadness. The diagnostic criteria could simply extend the current bereavement exclusion to cover conditions that develop after other losses and that are not especially severe or enduring.
Such a change would acknowledge what humans have always recognized: Intense sadness after loss is a painful and perhaps inevitable aspect of the human condition, but it is not necessarily a mental disorder.
Allan Horwitz is professor of sociology at Rutgers University. Jerome Wakefield is professor of social work and professor of the conceptual foundations of psychiatry at the School of Medicine, New York University.
COPYRIGHT: PROJECT SYNDICATE
The conflict in the Middle East has been disrupting financial markets, raising concerns about rising inflationary pressures and global economic growth. One market that some investors are particularly worried about has not been heavily covered in the news: the private credit market. Even before the joint US-Israeli attacks on Iran on Feb. 28, global capital markets had faced growing structural pressure — the deteriorating funding conditions in the private credit market. The private credit market is where companies borrow funds directly from nonbank financial institutions such as asset management companies, insurance companies and private lending platforms. Its popularity has risen since
The Donald Trump administration’s approach to China broadly, and to cross-Strait relations in particular, remains a conundrum. The 2025 US National Security Strategy prioritized the defense of Taiwan in a way that surprised some observers of the Trump administration: “Deterring a conflict over Taiwan, ideally by preserving military overmatch, is a priority.” Two months later, Taiwan went entirely unmentioned in the US National Defense Strategy, as did military overmatch vis-a-vis China, giving renewed cause for concern. How to interpret these varying statements remains an open question. In both documents, the Indo-Pacific is listed as a second priority behind homeland defense and
Every analyst watching Iran’s succession crisis is asking who would replace supreme leader Ayatollah Ali Khamenei. Yet, the real question is whether China has learned enough from the Persian Gulf to survive a war over Taiwan. Beijing purchases roughly 90 percent of Iran’s exported crude — some 1.61 million barrels per day last year — and holds a US$400 billion, 25-year cooperation agreement binding it to Tehran’s stability. However, this is not simply the story of a patron protecting an investment. China has spent years engineering a sanctions-evasion architecture that was never really about Iran — it was about Taiwan. The
After “Operation Absolute Resolve” to capture former Venezuelan president Nicolas Maduro, the US joined Israel on Saturday last week in launching “Operation Epic Fury” to remove Iranian supreme leader Ayatollah Ali Khamenei and his theocratic regime leadership team. The two blitzes are widely believed to be a prelude to US President Donald Trump changing the geopolitical landscape in the Indo-Pacific region, targeting China’s rise. In the National Security Strategic report released in December last year, the Trump administration made it clear that the US would focus on “restoring American pre-eminence in the Western hemisphere,” and “competing with China economically and militarily
RSS